Page 1 of Clinical Trials for Achillion Pharmaceuticals [SPONSOR-COLLABORATORS], 10 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.
Last Updated: August 18, 2009
Condition(s): Chronic Hepatitis B
2
Completed
Study of Once Daily Elvucitabine Versus Lamivudine in Subjects With a Documented M184V Mutation
Last Updated: October 30, 2007
Condition(s): HIV Infections
3
Terminated
Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B
Last Updated: August 18, 2009
Condition(s): Chronic Hepatitis B
4
Active, not recruiting
An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment
Last Updated: August 18, 2009
Condition(s): HIV Infections
5
Terminated
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ACH-0137171 in Subjects With Chronic Hepatitis C Infection
Last Updated: May 10, 2007
Condition(s): HCV Infection
6
Terminated
Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.
Last Updated: August 18, 2009
Condition(s): HIV Infections
7
Completed
Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment Naive Adults With Chronic Hepatitis B Virus Infection
Last Updated: July 20, 2006
Condition(s): Hepatitis B, Chronic
8
Completed
Open-Label, 48 Week Extension Study of Elvucitabine in Combination With Background ART For Subjects Who Have Completed Study ACH443-014A
Last Updated: August 18, 2009
Condition(s): HIV-1 Infection
9
Completed
Comparison of Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects
Last Updated: August 18, 2009
Condition(s): HIV Infections
10
Active, not recruiting
Safety, Tolerability and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in HCV Positive Subjects
Last Updated: January 11, 2012
Condition(s): Hepatitis C

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Achillion+Pharmaceuticals

Page 1 of Clinical Trials for Achillion Pharmaceuticals [SPONSOR-COLLABORATORS], 10 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About